Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome

Wei Fan, Bruce Boston, Robert A. Kesterson, Victor J. Hruby, Roger D. Cone

Research output: Contribution to journalArticle

1537 Citations (Scopus)

Abstract

DOMINANT alleles at the agouti locus (A) cause an obesity syndrome in the mouse, as a consequence of ectopic expression of the agouti peptide. This peptide, normally only found in the skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus explaining the inhibitory effect of agouti on eumelanin pigment synthesis. The agouti peptide is also an antagonist of the hypothalamic melanocortin-4 receptor (MC4-R). To test the hypothesis that agouti causes obesity by antagonism of hypothalamic melanocortin receptors, we identified cyclic melanocortin analogues that are potent agonists or antagonists of the neural MC3 (refs 11, 12) and MC4 receptors. Intracerebroventricular administration of the agonist, MTII, inhibited feeding in four models of hyperphagia: fasted C57BL/6J, ob/ob, and A(Y) mice, and mice injected with neuropeptide Y. Co- administration of the specific melanocortin antagonist and agouti-mimetic SHU9119 completely blocked this inhibition. Furthermore, administration of SHU9119 significantly enhanced nocturnal feeding, or feeding stimulated by a prior fast. Our data show that melanocortinergic neurons exert a tonic inhibition of feeding behaviour. Chronic disruption of this inhibitory signal is a likely explanation of the agouti obesity syndrome.

Original languageEnglish (US)
Pages (from-to)165-168
Number of pages4
JournalNature
Volume385
Issue number6612
DOIs
StatePublished - Jan 9 1997

Fingerprint

Obesity
Neurons
Receptor, Melanocortin, Type 4
Melanocortins
Peptides
Melanocortin Receptors
Hyperphagia
Neuropeptide Y
Feeding Behavior
Dasyproctidae
Alleles
Skin
Inhibition (Psychology)
SHU 9119

ASJC Scopus subject areas

  • General

Cite this

Fan, W., Boston, B., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997). Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome. Nature, 385(6612), 165-168. https://doi.org/10.1038/385165a0

Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome. / Fan, Wei; Boston, Bruce; Kesterson, Robert A.; Hruby, Victor J.; Cone, Roger D.

In: Nature, Vol. 385, No. 6612, 09.01.1997, p. 165-168.

Research output: Contribution to journalArticle

Fan, W, Boston, B, Kesterson, RA, Hruby, VJ & Cone, RD 1997, 'Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome', Nature, vol. 385, no. 6612, pp. 165-168. https://doi.org/10.1038/385165a0
Fan, Wei ; Boston, Bruce ; Kesterson, Robert A. ; Hruby, Victor J. ; Cone, Roger D. / Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome. In: Nature. 1997 ; Vol. 385, No. 6612. pp. 165-168.
@article{0c732901479349f9b076727aeb1b787b,
title = "Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome",
abstract = "DOMINANT alleles at the agouti locus (A) cause an obesity syndrome in the mouse, as a consequence of ectopic expression of the agouti peptide. This peptide, normally only found in the skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus explaining the inhibitory effect of agouti on eumelanin pigment synthesis. The agouti peptide is also an antagonist of the hypothalamic melanocortin-4 receptor (MC4-R). To test the hypothesis that agouti causes obesity by antagonism of hypothalamic melanocortin receptors, we identified cyclic melanocortin analogues that are potent agonists or antagonists of the neural MC3 (refs 11, 12) and MC4 receptors. Intracerebroventricular administration of the agonist, MTII, inhibited feeding in four models of hyperphagia: fasted C57BL/6J, ob/ob, and A(Y) mice, and mice injected with neuropeptide Y. Co- administration of the specific melanocortin antagonist and agouti-mimetic SHU9119 completely blocked this inhibition. Furthermore, administration of SHU9119 significantly enhanced nocturnal feeding, or feeding stimulated by a prior fast. Our data show that melanocortinergic neurons exert a tonic inhibition of feeding behaviour. Chronic disruption of this inhibitory signal is a likely explanation of the agouti obesity syndrome.",
author = "Wei Fan and Bruce Boston and Kesterson, {Robert A.} and Hruby, {Victor J.} and Cone, {Roger D.}",
year = "1997",
month = "1",
day = "9",
doi = "10.1038/385165a0",
language = "English (US)",
volume = "385",
pages = "165--168",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6612",

}

TY - JOUR

T1 - Role of melanocortlnergic neurons in feeding and the agouti obesity syndrome

AU - Fan, Wei

AU - Boston, Bruce

AU - Kesterson, Robert A.

AU - Hruby, Victor J.

AU - Cone, Roger D.

PY - 1997/1/9

Y1 - 1997/1/9

N2 - DOMINANT alleles at the agouti locus (A) cause an obesity syndrome in the mouse, as a consequence of ectopic expression of the agouti peptide. This peptide, normally only found in the skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus explaining the inhibitory effect of agouti on eumelanin pigment synthesis. The agouti peptide is also an antagonist of the hypothalamic melanocortin-4 receptor (MC4-R). To test the hypothesis that agouti causes obesity by antagonism of hypothalamic melanocortin receptors, we identified cyclic melanocortin analogues that are potent agonists or antagonists of the neural MC3 (refs 11, 12) and MC4 receptors. Intracerebroventricular administration of the agonist, MTII, inhibited feeding in four models of hyperphagia: fasted C57BL/6J, ob/ob, and A(Y) mice, and mice injected with neuropeptide Y. Co- administration of the specific melanocortin antagonist and agouti-mimetic SHU9119 completely blocked this inhibition. Furthermore, administration of SHU9119 significantly enhanced nocturnal feeding, or feeding stimulated by a prior fast. Our data show that melanocortinergic neurons exert a tonic inhibition of feeding behaviour. Chronic disruption of this inhibitory signal is a likely explanation of the agouti obesity syndrome.

AB - DOMINANT alleles at the agouti locus (A) cause an obesity syndrome in the mouse, as a consequence of ectopic expression of the agouti peptide. This peptide, normally only found in the skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus explaining the inhibitory effect of agouti on eumelanin pigment synthesis. The agouti peptide is also an antagonist of the hypothalamic melanocortin-4 receptor (MC4-R). To test the hypothesis that agouti causes obesity by antagonism of hypothalamic melanocortin receptors, we identified cyclic melanocortin analogues that are potent agonists or antagonists of the neural MC3 (refs 11, 12) and MC4 receptors. Intracerebroventricular administration of the agonist, MTII, inhibited feeding in four models of hyperphagia: fasted C57BL/6J, ob/ob, and A(Y) mice, and mice injected with neuropeptide Y. Co- administration of the specific melanocortin antagonist and agouti-mimetic SHU9119 completely blocked this inhibition. Furthermore, administration of SHU9119 significantly enhanced nocturnal feeding, or feeding stimulated by a prior fast. Our data show that melanocortinergic neurons exert a tonic inhibition of feeding behaviour. Chronic disruption of this inhibitory signal is a likely explanation of the agouti obesity syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0030614331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030614331&partnerID=8YFLogxK

U2 - 10.1038/385165a0

DO - 10.1038/385165a0

M3 - Article

VL - 385

SP - 165

EP - 168

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6612

ER -